Core technology

Metanovas combines advanced AI and machine learning with cutting edge science to decipher complex disease biology, generate novel insights and discover more effective medicines.

Target Discovery & Identification

Large scale knowledge graph combined with graph machine learning to discover novel disease targets

Virtual Screening

Advanced deep learning to screen for potential drugs

Lead Optimization

State-of-art ADMET property prediction and lead optimization

Drug Repurposing

Repurposing existing drugs for new indications


Metanovas has a team of talents from cross-disciplinary backgrounds in AI/ML, biology, drug discovery science and bioinformatics. Our AI team has researchers and industry veterans from MIT, Stanford, Google, Facebook, Amazon and NVIDIA. Our biology and drug discovery science team has researchers and scientists from FDA, BenevolentAI, Atomwise, MSKCC, Sanofi and Kite Pharma. The founding team has published on top journals and academic conferences with over 2000 citations.

Nucleic Acids Research


Nature Biotechnology

Association for the Advancement of Artificial Intelligence

Association for Computational Linguistics

PLOS Computational Biology

We are an AI + Life Science team. We use AI/ML to develop first-in-class drugs

Founding Team

Lun Yu, Ph.D.

Dr. Yu was Principal Data Scientist and Tech Lead at UnitedHealth Group. He holds a Ph.D. degree in engineering from MIT and two US patents.

Heng Luo, Ph.D.

Dr. Luo was Senior Scientist at Atomwise and BenevolentAI, and is veteran from FDA and IBM Watson. Dr. Luo holds a Ph.D. degree in bioinformatics and 40+ publications.

Tao Qing, Ph.D.

Dr. Qing was researcher at Yale University and holds a Ph.D. degree in pharmacogenomics. He has led multiple research collaborations with Merck and AstraZeneca.

Contact Us


Building B Room 605, 58 Xiangke Rd, Pudong District, Shanghai, China (Map) Boston, United States (Map)


+86 13501840429 +1 (857) 259-8455